We are happy to announce that the Novavax vaccine is being reviewed by the FDA for Emergency Use Authorization in adults, and they are opening a research study to children ages 12 to 17. We expect children ages 6 to 11 will be enrolling shortly. If you or someone you know is interested in enrolling their child in the study, please fill out the COVID Study Form or call 702-893-8968 for more information.
Qualified participants will receive:
- Study-related vaccine at no cost
- Study-related medical exams at no cost
- Compensation up to ($1800 ($150/VISIT) for time and travel
- School/work excuse notes available
|Now that multiple vaccines are readily available to choose from, why should I participate in a clinical trial?
— Continued vaccine research is essential in the fight against COVID-19. No single company can produce enough vaccines for the whole population. Also, each vaccine provides a different level of protection from the disease and the new variants and has specific side effects that need to be evaluated to determine which is better for which individuals.
|What’s in it for me?— There are many potential benefits. In addition to receiving free study-related medical care and compensation, your child’s participation in a clinical trial helps advance critical research that can ultimately save lives.|
|Why choose us?— Our number one priority is the safety of all trial participants. Your child will be under close supervision by highly trained medical professionals during the study and you will receive no-cost study-related medical care and attention.|
|Why should my child get vaccinated if children are less likely to get COVID-19?— According to the Centers for Disease Control and Prevention (CDC), while fewer children have been sick with COVID-19 compared to adults, children can be infected with the virus that causes COVID-19, can get sick from COVID-19, and can spread the virus that causes COVID-19 to others. The Centers for Disease Control and Prevention (CDC) are investigating a rare but serious medical condition associated with COVID-19 in children called Multisystem Inflammatory Syndrome in Children (MIS-C). Keep your child protected and consider a clinical research study for a COVID-19 vaccine for children.|